Mrv0541 04191212152D 13 13 0 0 0 0 999 V2000 -0.3515 2.0387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3160 1.5538 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0189 1.5538 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.7640 0.7692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1765 0.0547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0610 0.7692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4735 0.0547 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.8860 -0.6598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.1235 0.0547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7110 -0.6598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.1235 -1.3743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7640 -0.6598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.0015 0.0547 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 2 0 0 0 0 2 6 1 0 0 0 0 6 4 2 0 0 0 0 4 3 1 0 0 0 0 4 5 1 0 0 0 0 5 13 2 0 0 0 0 5 12 1 0 0 0 0 7 6 1 0 0 0 0 7 8 2 0 0 0 0 8 10 1 0 0 0 0 10 9 1 0 0 0 0 10 11 1 0 0 0 0 M END > T3D4689 > t3db > CN(C)N=NC1=C(N=CN1)C(N)=O > InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9) > FDKXTQMXEQVLRF-UHFFFAOYSA-N > C6H10N6O > 182.1832 > 182.091608972 > 5 > 17.775019330169545 > 1 > 2 > 0 > 0 > 5-(dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide > -0.32 > -0.42588896233333373 > -2.13 > 0 > 1 > -1 > 13.976988248823435 > 5.8902128485756595 > 1.7162548075264616 > 99.72999999999999 > 49.7106 > 3 > 1 > 1.36e+00 g/l > dacarbazine - dtic > 0 > T3D4689 > Dacarbazine > 4342-03-4 > 4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide; 4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide; 4-(Dimethyltriazeno)imidazole-5-carboxamide; 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide; 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide; 5-(Dimethyltriazeno)imidazole-4-carboxamide; Biocarbazine; Biocarbazine R; Dacarbazin; Dacarbazina; Dacarbazinum; Dacatic; Déticène; Detimedac; DIC; DTCI; DTIC; Dtic-Dome; Dtic-dome; DTIE; HSDB 3219; ICDMT; ICDT; Imidazole Carboxamide; NCI-C04717; NSC 45388; NSC-45388 > Organic Compound; Amine; Amide; Drug; Metabolite; Antineoplastic Agent, Alkylating; Synthetic Compound $$$$